Interventions for Mooren's ulcer

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 1, 2014, Pages

  Alhassan, Mahmoud B ^a   Rabiu, Mansur ^b   Agbabiaka, Idris O ^a  

^a National Eye Centre   (Nigeria)

^b Prevention of Blindness Union   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALEMTUZUMAB; ARTIFICIAL TEAR; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORINE; HEPARIN; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

CORNEA RODENT ULCER; CORNEA TRANSPLANTATION; EPIKERATOPLASTY; EYE SURGERY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KERATECTOMY; KERATOPLASTY; KERATOTOMY; PLASMA EXCHANGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; CORNEA ULCER;

CORNEAL ULCER; HUMANS;

EID: 84903788240     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006131.pub3     Document Type: Review

References (41)

1. Brown SI. Mooren's ulcer treatment by conjunctival excision. British Journal of Ophthalmology 1975;59(11):675-82.
2. Chen J, Xie H, Wang Z, Yang B, Liu Z, Chen L, et al.Mooren's ulcer in China: a study of clinical characteristics and treatment. British Journal of Ophthalmology 2000;84(11):1244-9.
3. Chen KH, Hsu WM, Liang CK. Relapsing Mooren's ulcer after amniotic membrane transplant combined with conjunctival autograft. Ophthalmology 2004;111(4):792-5.
4. Chow CY, Foster CS. Mooren's ulcer. International Ophthalmology Clinics 1996;36(1):1-13.
5. Erdem U, Kerimoglu H, Gundogan FC, Dagli S. Treatment of Mooren's ulcer with topical administration of interferon alfa 2a. Ophthalmology 2007;114(3):446-9.
6. Fontana L, Parente G, Neri P, Reta M, Tassinari G. Favourable response to infliximab in a case of bilateral Mooren's ulcer. Clinical and Experimental Ophthalmology 2007;35(9):871-3.
7. Hill JC, Potter P. Treatment of Mooren's ulcer with cyclosporin A: a report of three cases. British Journal of Ophthalmology 1987;71(1):11-5.
8. Kalogeropulous CD, Malamou-Mitsi VD, Aspiotis MB, Psilas KG. Bilateral Mooren's ulcer in six patients: diagnosis, surgery and histopathology. International Ophthalmology 2004;25(1):1-8.
9. Mavrakanas NA, Kiel R, Dosso AA. Autologous serum application in the treatment of Mooren's ulcer. Klinische Monatsblatter fur Augenheilkunde 2007;224(4):300-2.
10. Miyazaki D, Tominaga T, Kakimaru-Hasegawa A, Nagata Y, Hasegawa J, Inoue Y. Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases. Ophthalmology 2008;115(6):988-92.
11. Sangwan VS, Zafirakis P, Foster CS. Current concepts in management of Mooren's ulcer. Indian Journal of Ophthalmology 1997;45(1):7-17.
12. Sharma A, Vishawanath KB, Mohan K. Critical analysis of management options in Mooren's ulcer. All India Ophthalmological Society. Jan 2005.
13. Shimmura S, Igarashi R, Yaguchi H, Ohashi Y, Shimazaki J, Tsubota K. Lecithin-bound superoxide dismutase in the treatment of noninfectious corneal ulcers. American Journal of Ophthalmology 2003;135(5):613-9.
14. Spelsberg H, Sundmacher R. Amniotic membrane transplantation and high dose systemic cyclosporin A (Sandimmun optoral) for Mooren's ulcer. Klinische Monatsblatter fur Augenheilkunde 2007;224(2):135-9.
15. Tandon R, Chawla B, Verma K, Sharma N, Titiyal JS. Treatment of Mooren's ulcer with cyclosporin a 2%. Cornea 2008;27(8):859-61.
16. Tiev KP, Borderie VM, Briant M, Ziani M, Morvant C, Baret M, et al.Severe Mooren's ulcer: efficacy of monthly cyclophosphamide intravenous pulse treatment [Ulceres de Mooren severes: efficacite du traitement par cyclophosphamide en bolus intraveineux mensuels]. La Revue de Medecine Interne 2003;24(2):118-22.
17. Van der Hoek J, Azuare-Blanco A, Greiner K, Forrester JV. Mooren's ulcer resolved with campath-1H. British Journal of Opthalmology 2003;87(7):924-5.
18. Xie H, Chen J, Wang Z, Yang B, Gong X, Feng C, et al.Microsurgical treatment of bilateral Mooren's ulcer. Microsurgery 2003;23(1):27-31.
19. Zegans ME, Srinivasan M. Mooren's ulcer. International Opthalmology Clinics 1998;38(4):81-8.
20. Zhao JC, Jin XY. Immunological analysis and treatment of Mooren's ulcer with cyclosporin A applied topically. Cornea 1993;12(6):481-8.
21. Alhassan MB. Mooren's ulcer: clinical types and treatment outcome. Ophthalmological Society of Nigeria Annual Conference; Abuja, Nigeria. 1999.
22. Bouchard CS. Mooren's Ulcer. In: Yannoff M, Duker JS editor(s). Ophthalmology. St Louis: Mosby, 1998.
23. Brown SI, Mondino BJ. Therapy of Mooren's ulcer. American Journal of Ophthalmology 1984;98(1):1-6.
24. Foster CS. Systemic immunosuppressive therapy for progressive bilateral Mooren's ulcer. Ophthalmology 1985;92(10):1436-9.
25. Foster CS. Immunologic disorders of the conjunctiva, cornea and sclera. In: Albert DM, Jakobiec FA editor(s). Principles and Practice of Ophthalmology. 2nd Edition. Philadelphia: WB Saunders, 1999:803-28.
26. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
27. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
28. Kanski JJ. Clinical Ophthalmology: A Systematic Approach. 5th Edition. Philadelphia: Butterworth-Heinemann, 2003:117-9.
29. Kinoshita S, Ohashi Y, Ohji M, Manabe R. Long-term results of keratoepithelioplasty in Mooren's ulcer. Ophthalmology 1991;98(4):438-45.
30. Moazami G, Auran JD, Florakis GJ, Wilson SE, Srinivasan DB. Interferon treatment of Mooren's ulcers associated with hepatitis C. American Journal of Ophthalmology 1995;119(3):365-6.
31. Taylor CJ, Smith SI, Morgan CH, Stephenson SF, Key T, Srinivasan M, et al.HLA and Mooren's ulceration. British Journal of Ophthalmology 2000;84(1):72-5.
32. Tuft S. Mooren's Ulcer. In: Johnson GJ, Minassian DC, Weale RA, West SK editor(s). Epidemiology of Eye Disease. London: Arnold, 2003:209-11.
33. Van der Gaag R, Abdillahi H, Stilma JS, Vetter JCM. Circulating antibodies against cornea epithelium and hookworm in patients with Mooren's ulcer in Sierra Leone. British Journal of Ophthalmology 1983;67(9):623-8.
34. Watson PG. Management of Mooren's ulceration. Eye 1997;11(3):349-56.
35. Wilhelmus KR, Huang AJ, Hwang DG, Parrish CM, Sutphin JE, Whitsett JC. External disease and cornea. In: Liesegang TJ, Deutsch TA, Grand MG editor(s). Basic and Clinical Science Course for Ophthalmologists Section 8. San Francisco, CA: American Academy of Ophthalmology, 2001:217-8.
36. Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA. Mooren-type hepatitis C virus-associated corneal ulceration. Ophthalmology 1994;101(4):736-45.
37. Wormald R. Bridging the gap to evidence based eye care. Community Eye Health Journal 2004;17(51):40-1.
38. Young RG, Watson PG. Light and electron microscopy of corneal melting syndrome (Mooren's ulcer). British Journal of Ophthalmology 1982;66(6):341-56.
39. Zelefsky JR, Srinivasan M, Kundu A, Lietman T, Whitcher JP, Cunningham ET Jr. Hookworm infestation as a risk factor for Mooren's ulcer in South India. Ophthamology 2007;114(3):450-3.
40. Alhassan MB, Rabiu M, Agbabiaka IO. Interventions for Mooren's ulcer. Cochrane Database of Systematic Reviews 2011, Issue 6. [DOI: 10.1002/14651858.CD006131.pub2]
41. Rabiu M, Alhassan MB, Agbabiaka IO. Interventions for Mooren's ulcer. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD006131]